Daxor

Optimal Volume Management is Key to COVID -19 Survivability

BVA-100 Key Features

Blood Volume Analyzer

• 98% accurate measure of total blood, plasma and red cell volume
• Simple blood test with results ready in less than 6O minutes
• Quantifies volume deviation vs patient-specific ideals
• Unique measure of capillary permeability

Discover More

Rapid. Accurate. Individualized. Actionable. Reimbursed.

Rapid.
Accurate.
Individualized.
Actionable.
Reimbursed.

Token Sale

Heart Failure

56% Reduction in 30-Day Readmissions
82% Reduction in 30-Day Mortality
86% Reduction in 365-Day Mortality
62% Identified as Anemic

Discover More

Critical Care

66% Reduction in Mortality
20% Reduction in Length of Stay
36 Hour Earlier Treatment Decisions
44% Change in Treatment Strategy

Discover More

Published research from leading
institutions has established the value of the BVA-100

Cleveland Clinic • Columbia • Mayo Clinic
NYU • Yale • Vanderbilt • Virginia Commonwealth University

Published research from leading
institutions has established the value of the BVA-100

• NYU

• Virginia Commonwealth University

View Our Story

BVA-100 Impact Points

Token Sale

Providers

Enables better clinical decisions to improve quality of care

Payers

Reduces mortality and readmissions and lowers the cost of care

Patients

Provides your doctor with the information needed to optimize treatment

Discover More

Token Sale

Providers

Enables better clinical decisions to improve quality of care

Discover More

Payers

Reduces mortality and readmissions and lowers the cost of care

Discover More

Patients

Provides your doctor with the information needed to optimize treatment

Discover More

Token Sale

News & Events

11 Oct 2020

Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl

06 Oct 2020

New Research Shows Daxor’s BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020

05 Oct 2020

New Research Demonstrates Daxor BVA-100® Blood Test Provides “Extremely Cost-Effective” Improvement in Patient Life Span at the Heart Failure Society of America Annual Scientific Meeting 2020

Special Report

Read the Report

Watch our CEO speak with Varney & Co. at Fox Business
to discuss how BVA Technology and its applications are
joining the fight against COVID-19.

Watch the Interview

Token Sale

Daxor Corporation is an innovative medical instrumentation and biotechnology company focused on blood volume analysis.

Token Sale

The BVA-100 is an FDA-cleared diagnostic instrument to measure a patient’s blood volume, calculate an ideal blood volume that the patient should have, and indicate hypovolemia or hypervolemia with statistics showing the quality of results.

Contact Us

865-425-0555
info@daxor.com

56% Reduction in 30-Day Readmissions 82% Reduction in 30-Day Mortality 86% Reduction in 365-Day Mortality 62% Identified as Anemic

66% Reduction in Mortality 20% Reduction in Length of Stay 36 Hour Earlier Treatment Decisions 44% Change in Treatment Strategy

56% Reduction in 30-Day Readmissions
82% Reduction in 30-Day Mortality
86% Reduction in 365-Day Mortality
62% Identified as Anemic

66% Reduction in Mortality
20% Reduction in Length of Stay
36 Hour Earlier Treatment Decisions
44% Change in Treatment Strategy